I'm A Patient
I'm A ProviderSee What’s Possible with a New Approach to Dry AMD
Dry age-related macular degeneration not only affects your eyesight, but it also impacts your ability to live life fully.
Recognizing loved ones’ faces, enjoying a good book, or driving at night can all become daily challenges. But now there’s hope.
MacuMira offers new hope for people diagnosed with this condition. It is the first Health Canada–licensed, noninvasive therapy proven to improve visual function in patients with dry AMD.
Safe and painless, MacuMira has improved the visual function in thousands of dry AMD patients across Canada and beyond.
How MacuMira Works
Microcurrent Stimulation
MacuMira gently delivers low-level microcurrent through the closed eyelids to stimulate the retina. This therapy is designed to support retinal health and maintain or improve your vision over time. It’s designed to improve and preserve vision in patients with dry AMD.
Improved Vision
Many patients report noticing clearer vision or improved contrast within the first 10 days of treatment. Eye care providers typically recommend ongoing follow-up sessions every 3 months to maintain the effects.
Comfortable, In-Office Therapy
MacuMira does not require needles, medications, lasers, or surgery. Treatments are quick, typically 32 minutes, and most patients can return to their regular day right after their visit.
Understanding Dry Age-Related Macular Degeneration
Dry age-related macular degeneration (dry AMD) affects the macula, the part of your retina responsible for detailed, central vision. As the condition progresses, everyday tasks like recognizing faces, reading fine print, or seeing clearly in dim light can become difficult.
Dry AMD doesn’t cause complete blindness, as it typically does not affect peripheral (side) vision. However, in advanced stages, it can lead to severe central vision loss, making everyday activities like reading, driving, and recognizing faces extremely difficult.
The early stages of dry AMD don’t typically cause any symptoms. This means a person can have damage to their macula and not realize it.
Regular eye exams are important for detecting the condition early. MacuMira may be able to help slow the progression of dry AMD while improving vision.
In dry AMD, the light-sensitive cells in the macula gradually break down. One of the earliest changes is the accumulation of drusen—small yellow deposits beneath the retina.
These deposits can interfere with the retina’s function and may signal the start of vision decline. Early on, dry AMD may not cause noticeable symptoms, but as it advances, many people begin to experience:
- Blurry or fuzzy central vision
- Trouble reading or recognizing faces
- Difficulty seeing clearly in dim lighting
- Wavy or distorted lines
Dry AMD does not typically affect peripheral (side) vision, but in later stages, it can result in severe central vision loss, making it harder to do things like drive, read, or navigate daily routines independently.
Dry AMD can affect anyone, but certain factors can increase the risk:
- Age: The likelihood rises sharply after age 55
- Family history: Genetics play a significant role in AMD development
- Smoking: Smoking significantly increases risk and speeds up disease progression
- Lifestyle: Poor nutrition and lack of regular eye exams can also contribute
Because early dry AMD often has no symptoms, routine eye exams are key to early detection and timely management.
A comprehensive eye exam can reveal early signs of macular changes long before vision is affected. Eye care providers can identify drusen, retinal thinning, or other subtle markers during routine imaging. Detecting dry AMD in its earliest stages enables patients and providers to explore new treatment options, such as MacuMira.
A Proven Treatment Option for Dry AMD in Canada
Until recently, people living with dry AMD had limited tools for preserving their vision. Most management strategies focused on slowing progression through lifestyle changes or vitamins. But they did not restore what was already lost.
With MacuMira, that’s changed.
MacuMira is the first and only Health Canada–licensed, noninvasive treatment clinically shown to improve visual function in patients with dry AMD.
Our mission is to bring innovation to AMD treatment.
If no one is currently offering MacuMira in your area, please ask your current eye care provider to contact us to learn more.
Patients: Contact Us for More Information About MacuMira
Articles
Understanding how dry AMD affects you or your family member can make it a little easier to navigate. Learn more about this eye disease in our articles.
Your Guide to Dry Age-related Macular Degeneration: Key Treatments and Care Strategies
BlogDry age-related macular degeneration (AMD) is a progressive eye condition that affects the macula, leading to gradual central vision loss. As the most common form of AMD, it typically develops slowly. Early detection and management are crucial for maintaining eye health. Understanding In dry AMD, the macula thins over time, often accompanied by the formation of […]
Can Wet Macular Degeneration Turn Into Dry Macular Degeneration?
BlogAge-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults. It comes in two forms: dry (atrophic) and wet (neovascular). While dry AMD progresses gradually over time, wet AMD can cause sudden and severe vision loss. A common question among patients and caregivers is whether wet macular degeneration can turn […]
Read More… from Can Wet Macular Degeneration Turn Into Dry Macular Degeneration?
What is geographic atrophy (GA)?
BlogHow it’s related to dry AMD and who’s the most at risk For those with dry age-related macular degeneration (dry AMD), there’s always a risk that this condition could develop into geographic atrophy (GA), a condition where retinal pigment epithelial (RPE) cells start to die off. Research estimates that there are approximately 180,000 new cases of GA […]
Your Guide to Dry Age-related Macular Degeneration: Key Treatments and Care Strategies
Dry age-related macular degeneration (AMD) is a progressive eye condition that affects the macula, leading to gradual central vision loss. As the most common form of AMD, it typically develops slowly. Early detection and management are crucial for maintaining eye health. Understanding In dry AMD, the macula thins over time, often accompanied by the formation of […]
Can Wet Macular Degeneration Turn Into Dry Macular Degeneration?
Age-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults. It comes in two forms: dry (atrophic) and wet (neovascular). While dry AMD progresses gradually over time, wet AMD can cause sudden and severe vision loss. A common question among patients and caregivers is whether wet macular degeneration can turn […]
Read More… from Can Wet Macular Degeneration Turn Into Dry Macular Degeneration?
What is geographic atrophy (GA)?
How it’s related to dry AMD and who’s the most at risk For those with dry age-related macular degeneration (dry AMD), there’s always a risk that this condition could develop into geographic atrophy (GA), a condition where retinal pigment epithelial (RPE) cells start to die off. Research estimates that there are approximately 180,000 new cases of GA […]
Patients
Eye Care Providers
Select your Country
Corporate:
#302, 815 – 1st Street SW
Calgary, AB
T2P 1N3
info@macumira.com
1-844-619-6263
Mailing Address:
MacuMira Medical Devices Inc
#136 1811 4th Street SW
Calgary, AB
T2S 1W2
Hours:
Mon-Fri: 8am – 5pm
Sat – Sun: Closed